✦ LIBER ✦

Cytogenetic Remissions Induced by Interferon α and Imatinib Mesylate are Immunologically Distinct in Chronic Myeloid Leukemia

✍ Scribed by Shin Nakayama; Tokiko Nagamura-Inoue; Kazuaki Yokoyama; Nobuhiro Ohno; Jun Ooi; Satoshi Takahashi; Kaoru Uchimaru; Toru Iseki; Arinobu Tojo

Book ID: 111835725
Publisher: Carden Jennings Publishing
Year: 2007
Tongue: English
Weight: 124 KB
Volume: 86
Category: Article
ISSN: 0925-5710
DOI: 10.1532/ijh97.07099

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytogenetic remissions induced by interf

Cytogenetic remissions induced by interferon α and imatinib mesylate are immunologically distinct in chronic myeloid leukemia

✍ Shin Nakayama; Tokiko Nagamura-Inoue; Kazuaki Yokoyama; Nobuhiro Ohno; Jun Ooi; 📂 Article 📅 2007 🏛 Carden Jennings Publishing 🌐 English ⚖ 124 KB

CD34+/Ph+ cells are still detectable in

CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate

✍ Bocchia, M; Ippoliti, M; Gozzetti, A; Abruzzese, E; Calabrese, S; Amabile, M; Pi 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

Sustained Cytogenetic Remission Induced

Sustained Cytogenetic Remission Induced by Imatinib Mesylate in a Chronic Myeloid Leukemia Patient Who Had a Relapse into Lymphoid Crisis after Allogeneic Hematopoietic Stem Cell Transplantation

✍ Toshiaki Yujiri; Yutaka Sato; Yukio Tanizawa 📂 Article 📅 2004 🏛 Carden Jennings Publishing 🌐 English ⚖ 55 KB

Efficacy and safety of imatinib in patie

Efficacy and safety of imatinib in patients with chronic myeloid leukemia and complete or near-complete cytogenetic response to interferon-α

✍ Susan Branford; Timothy Hughes; Alvin Milner; Rachel Koelmeyer; Anthony Schwarer 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 2 views

## Abstract ## BACKGROUND. Interferon‐alpha (IFN‐α) confers a survival advantage for the minority of patients with chronic myeloid leukemia (CML) who achieve a complete cytogenetic response. The question of whether IFN‐α‐responsive patients can experience further improvements with imatinib has not

Defective blood dendritic cells in chron

Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate

✍ Boissel, N; Rousselot, P; Raffoux, E; Cayuela, J-M; Maarek, O; Charron, D; Degos 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 290 KB

Imatinib Mesylate Therapy Induces Reduct

Imatinib Mesylate Therapy Induces Reduction in Neutrophil Gelatinase-Associated Lipocalin Serum Levels and Increase in Leptin Concentrations in Chronic Myeloid Leukemia Patients in Molecular Remission

✍ Alonci, Andrea; Allegra, Alessandro; Russo, Sabina; Penna, Giuseppa; Bellomo, Gi 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 165 KB